The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

European Journal of Pharmacology

Volumn 273, Issue 3, 1995, Pages 273-279

  Schmidt, Christopher J ^a   Fadayel, Gina M ^a  

^a Merrell Dow Research Institute   (United States)

Author keywords

5 HT2 receptor; Antipsychotic; Clozapine; Microdialysis; Prefrontal cortex

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; DOPAMINE; FLUOROBENZENE; HOMOVANILLIC ACID; PIPERIDINE DERIVATIVE; RITANSERIN; SEROTONIN ANTAGONIST; CLOZAPINE; NEUROLEPTIC AGENT; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; ELECTROPHYSIOLOGY; IN VITRO STUDY; MALE; METABOLISM; MICRODIALYSIS; PREFRONTAL CORTEX; RAT; RAT STRAIN; ANIMAL EXPERIMENT; CONTROLLED STUDY; DOPAMINE RELEASE; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL; BEHAVIOR, ANIMAL; DOPAMINE; ELECTROPHYSIOLOGY; FLUOROBENZENES; HOMOVANILLIC ACID; IN VITRO; MALE; MICRODIALYSIS; PIPERIDINES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RITANSERIN; SEROTONIN ANTAGONISTS;

EID: 0028978933     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(94)00698-7     Document Type: Article

References (44)

1. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
2. Effects of amperozide in schizophrenia
3. Memory and frontal lobe dysfunction in schizophrenia and schizoaffective disorder
4. The regulation of subcortical dopamine systems by the prefrontal cortex: interaction of central dopamine systems and the pathogenesis of schizophrenia
5. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress
6. 2/1C antagonist, and negative symptoms in schizophrenia
7. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
8. Burst firing induced in mid-brain dopamine neurons by stimulation of the median prefrontal and anterior cingulate cortices
9. Further evidence for dementia of the prefrontal type in schizophrenia
10. Recall memory deficit in schizophrenia: a possible manifestation of prefrontal dysfunction
11. Effects of mesocortical dopamine lesions upon subcortical dopaminergic function
12. 1C agonists suppress apomorphine-induced locomotor activity
13. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus
14. Clozapine for the treatment resistant schizophrenic
15. 1C receptors mediate 1–3(chlorophenyl)piperazine-induced hypophagia
16. Lesions of the dopamine neurons in the median prefrontal cortex: effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat
17. 2 receptors, roles and regulation
18. 2 receptors
19. Opposite influence of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens
20. 2 antagonist
21. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
22. The importance of serotonin-dopamine interactions in the action of clozapine
23. i values
24. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens and straitum of the rat: an in vivo microdialysis study
25. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo
26. 2 antagonists
27. 2 receptor occupancy in clozapine treated patients demonstrated by PET
28. 3 mediated control of dopaminergic function
29. Local administration of ritanserin or ICS 205,930 enhances dopamine and serotonin efflux in rat prefrontal cortex
30. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux
31. 3 receptor activation in the rat dentate gyrus
32. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
33. 2 receptor blocker
34. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems
35. 1C receptors
36. In vivo release of dopamine from rat stratum, substantia nigra and prefrontal cortex: differential modulation by baclofen
37. 2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxy-methamphetamine
38. 2 receptors in schizophrenia and antipsychotic activity
39. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholaminergic terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
40. 2 receptors in interneurons
41. 2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies
42. A review of clozapine: an antipsychotic for treatment-resistant schizophrenia
43. Electrical stimulation of the median prefrontal cortex increases dopamine release in the striatum
44. Schizophrenia and the frontal lobe